Crystalline form c of the sodium salt of the acid (4 - (4 - (5 - (6 - trifluoro Methyl amino - pyridin-3-yl) pyridin-2-yl) phenyl) - cyclohexyl) - acetic acid; Preparation Process; Pharmaceutical composition containing same and their use for the treatment of a disorder associated with the activity of the dagt.

摘要

The present invention relates to novel crystalline forms of (4-{4-[5-(6-Trifluoromethylpyridin-3-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid, sodium and their use in the treatment or prevention of a condition or a disorder associated with DGAT1 activity in animals, particularly humans. It also relates processes for making such novel crystalline forms.